Paul David Bach Sells 12,418 Shares of Genesis Healthcare Inc (NYSE:GEN) Stock

Genesis Healthcare Inc (NYSE:GEN) COO Paul David Bach sold 12,418 shares of the firm’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $1.17, for a total transaction of $14,529.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Paul David Bach also recently made the following trade(s):

  • On Monday, June 3rd, Paul David Bach sold 8,616 shares of Genesis Healthcare stock. The stock was sold at an average price of $1.16, for a total transaction of $9,994.56.
  • On Monday, May 20th, Paul David Bach sold 11,540 shares of Genesis Healthcare stock. The stock was sold at an average price of $1.20, for a total transaction of $13,848.00.

Genesis Healthcare stock traded up $0.02 during trading hours on Friday, hitting $1.21. 2,805 shares of the company traded hands, compared to its average volume of 258,155. The stock has a market cap of $196.56 million, a price-to-earnings ratio of -0.79 and a beta of 0.98. Genesis Healthcare Inc has a 1-year low of $1.10 and a 1-year high of $2.86.

Genesis Healthcare (NYSE:GEN) last announced its quarterly earnings data on Thursday, May 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.25) by $0.10. The business had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.17 billion. On average, equities research analysts anticipate that Genesis Healthcare Inc will post -0.72 earnings per share for the current year.

Several hedge funds have recently bought and sold shares of GEN. Vanguard Group Inc boosted its holdings in shares of Genesis Healthcare by 0.5% during the third quarter. Vanguard Group Inc now owns 2,424,601 shares of the company’s stock worth $3,273,000 after purchasing an additional 12,253 shares during the period. Rhumbline Advisers raised its position in shares of Genesis Healthcare by 51.3% in the fourth quarter. Rhumbline Advisers now owns 68,297 shares of the company’s stock valued at $81,000 after purchasing an additional 23,160 shares during the period. Acadian Asset Management LLC raised its position in shares of Genesis Healthcare by 14.7% in the fourth quarter. Acadian Asset Management LLC now owns 1,691,866 shares of the company’s stock valued at $1,996,000 after purchasing an additional 217,438 shares during the period. California Public Employees Retirement System raised its position in shares of Genesis Healthcare by 8.4% in the fourth quarter. California Public Employees Retirement System now owns 383,258 shares of the company’s stock valued at $452,000 after purchasing an additional 29,807 shares during the period. Finally, Columbia Pacific Advisors LLC raised its position in shares of Genesis Healthcare by 1.0% in the fourth quarter. Columbia Pacific Advisors LLC now owns 3,229,829 shares of the company’s stock valued at $3,811,000 after purchasing an additional 32,374 shares during the period. Institutional investors and hedge funds own 21.34% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Paul David Bach Sells 12,418 Shares of Genesis Healthcare Inc (NYSE:GEN) Stock” was originally posted by Modern Readers and is the sole property of of Modern Readers. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://www.modernreaders.com/news/2019/06/14/paul-david-bach-sells-12418-shares-of-genesis-healthcare-inc-nysegen-stock.html.

About Genesis Healthcare

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Featured Article: Current Ratio

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.